RBR-5pygzhjRecruiting
A clinical trial to evaluate the feasibility and efficacy of using Anastrozole before surgery for patients with hormone-related localized Breast Cancer with low proliferative capacity
A phase II single-arm clinical trial to evaluate the feasibility and efficacy of Neoadjuvant Anastrozole in luminal, low proliferative index Breast Cancer patients at TNM stages II and III
Hospital de Câncer de BarretosPhase 2Registro Brasileiro De Ensaios Clinicos
VerifiedRegistro Brasileiro De Ensaios Clinicos
Study focus
- Disease/Condition
- Malignant neoplasm of breast
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Hospital de Câncer de Barretos
- Location
- Brazil
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Jul 20, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastPersonal history of malignant neoplasm of breast
Data source
- Registry
- Registro Brasileiro De Ensaios Clinicos
- Trial ID
- RBR-5pygzhj
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for RBR-5pygzhj through Pure Global AI's free database. This Phase 2 trial is sponsored by Hospital de Câncer de Barretos and is currently Recruiting. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Registro Brasileiro De Ensaios Clinicos data, helping medical device and pharmaceutical companies navigate clinical research efficiently.